Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
4 studies found for:    miksad
Show Display Options
Rank Status Study
1 Completed
Has Results
Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma
Condition: Pancreatic Cancer
Interventions: Drug: Capecitabine;   Drug: Oxaliplatin
2 Active, not recruiting Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
Condition: Hepatocellular Cancer
Interventions: Drug: Sorafenib;   Procedure: radiofrequency ablation
3 Not yet recruiting Pembrolizumab in Refractory Advanced Esophageal Cancer
Conditions: Esophageal Cancer;   Squamous Cell Esophagus Cancer;   Adenocarcinoma Esophagus
Intervention: Drug: Pembrolizumab
4 Recruiting Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder
Conditions: Carcinoma of Intrahepatic and Extra-hepatic Biliary System;   Carcinoma of Gallbladder;   Bile Duct Cancer;   Cholangiocarcinoma
Interventions: Drug: DKN-01;   Drug: gemcitabine;   Drug: cisplatin

Study has passed its completion date and status has not been verified in more than two years.